{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(4)"],"submitter":["Ando H"],"pubmed_abstract":["Both peri-stent contrast staining (PSS) and late restenosis are abnormal findings after drug-eluting stent implantation and they occur with low incidence. We describe a case with two PSSs and one late restenosis after sirolimus-eluting stent implantation. Persistent high value of C-reactive protein in this patient suggested chronic systematic inflammation as a contributing factor of these abnormal findings. <Learning objective: The advent of drug-eluting stents has dramatically reduced in-stent restenosis. However, there are still some concerns about long-term safety. We show a case with multiple sirolimus-eluting stent-related complications, taking into account the underlying pathogenesis.>."],"journal":["Journal of cardiology cases"],"pagination":["145-147"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6281823"],"repository":["biostudies-literature"],"pubmed_title":["Two peri-stent contrast stainings and one late restenosis in the late phase after sirolimus-eluting stent implantation."],"pmcid":["PMC6281823"],"pubmed_authors":["Amano T","Takashima H","Ando H","Uetani T","Murohara T"],"additional_accession":[]},"is_claimable":false,"name":"Two peri-stent contrast stainings and one late restenosis in the late phase after sirolimus-eluting stent implantation.","description":"Both peri-stent contrast staining (PSS) and late restenosis are abnormal findings after drug-eluting stent implantation and they occur with low incidence. We describe a case with two PSSs and one late restenosis after sirolimus-eluting stent implantation. Persistent high value of C-reactive protein in this patient suggested chronic systematic inflammation as a contributing factor of these abnormal findings. <Learning objective: The advent of drug-eluting stents has dramatically reduced in-stent restenosis. However, there are still some concerns about long-term safety. We show a case with multiple sirolimus-eluting stent-related complications, taking into account the underlying pathogenesis.>.","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Apr","modification":"2025-04-21T15:02:10.326Z","creation":"2019-03-27T00:13:09Z"},"accession":"S-EPMC6281823","cross_references":{"pubmed":["30546786"],"doi":["10.1016/j.jccase.2013.12.008"]}}